Comparative efficacy and safety of different antiplatelet agents for prevention of major cardiovascular events and leg amputations in patients with peripheral arterial disease: A systematic review and network meta- analysis

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Katsanos, Konstantinos ^a,b   Spiliopoulos, Stavros ^b   Saha, Prakash ^c   Diamantopoulos, Athanasios ^a   Karunanithy, Narayan ^a   Krokidis, Miltiadis ^d   Modarai, Bijan ^c   Karnabatidis, Dimitris ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CLOPIDOGREL; PICOTAMIDE; TICAGRELOR; TICLOPIDINE; VORAPAXAR;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HEART DEATH; HEART INFARCTION; HEART PROTECTION; HUMAN; LEG AMPUTATION; LEG REVASCULARIZATION; META ANALYSIS; MONOTHERAPY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; AMPUTATION; CHEMICALLY INDUCED; COMPARATIVE STUDY; FACTUAL DATABASE; FEMALE; LEG; MALE; MYOCARDIAL INFARCTION; PERIPHERAL ARTERIAL DISEASE; POSTOPERATIVE COMPLICATIONS; STROKE;

AMPUTATION; DATABASES, FACTUAL; FEMALE; HEMORRHAGE; HUMANS; LEG; MALE; MYOCARDIAL INFARCTION; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE;

EID: 84942845435     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135692     Document Type: Article

References (40)

1. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013; 382(9901):1329-40. Epub 2013/08/07. doi: 10.1016/ S0140-6736(13)61249-0 PMID: 23915883.
2. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. The New England journal of medicine. 1992; 326 (6):381-6. Epub 1992/02/06. doi: 10.1056/NEJM199202063260605 PMID: 1729621.
3. Criqui MH, Ninomiya JK, Wingard DL, Ji M, Fronek A. Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. Journal of the American College of Cardiology. 2008; 52(21):1736-42. Epub 2008/11/15. doi: 10.1016/j.jacc.2008.07.060 PMID: 19007695; PubMed Central PMCID: PMC2871035.
4. Katsanos K, Tepe G, Tsetis D, Fanelli F. Standards of practice for superficial femoral and popliteal artery angioplasty and stenting. Cardiovascular and interventional radiology. 2014; 37(3):592-603. Epub 2014/04/12. doi: 10.1007/s00270-014-0876-3 PMID: 24722891.
5. NICE. Clinical Guideline 147: Lower Limb Peripheral Arterial Disease: Diagnosis and Management. National Clinical Guideline Centre. August 2012; Available: http://www.nice.org.uk.
6. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery. 2007; 33 Suppl 1: S1-75. Epub 2006/12/05. doi: 10.1016/j.ejvs.2006.09.024 PMID: 17140820.
7. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. Journal of vascular surgery. 2011; 54(5):e32-58. Epub 2011/10/01. doi: 10.1016/j.jvs.2011.09.001 PMID: 21958560.
8. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, Collet JP, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). European heart journal. 2011; 32(22):2851-906. Epub 2011/08/30. doi: 10.1093/ eurheartj/ehr211 PMID: 21873417.
9. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002; 324(7329):71-86. Epub 2002/01/12. PMID: 11786451; PubMed Central PMCID: PMC64503.
10. Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA: the journal of the American Medical Association. 2009; 301(18):1909-19. Epub 2009/05/14. doi: 10.1001/jama.2009. 623 PMID: 19436018.
11. Wijeyeratne YD, Heptinstall S. Anti-platelet therapy: ADP receptor antagonists. British journal of clinical pharmacology. 2011; 72(4):647-57. Epub 2011/04/27. doi: 10.1111/j.1365-2125.2011.03999.x PMID: 21518389; PubMed Central PMCID: PMC3187865.
12. Thompson PD, Zimet R, Forbes WP, Zhang P. Meta-analysis of results from eight randomized, placebo- controlled trials on the effect of cilostazol on patients with intermittent claudication. The American journal of cardiology. 2002; 90(12):1314-9. Epub 2002/12/14. PMID: 12480040.
13. Neri Serneri GG, Coccheri S, Marubini E, Violi F. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study. European heart journal. 2004; 25(20):1845-52. Epub 2004/10/12. doi: 10.1016/j.ehj.2004.07. 013 PMID: 15474700.
14. Bonaca MP, Scirica BM, Creager MA, Olin J, Bounameaux H, Dellborg M, et al. Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P-TIMI 50. Circulation. 2013; 127(14):1522- 9, 9e1-6. Epub 2013/03/19. doi: 10.1161/CIRCULATIONAHA.112.000679 PMID: 23501976.
15. Katsanos K, Spiliopoulos S, Karunanithy N, Krokidis M, Sabharwal T, Taylor P. Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery. Journal of vascular surgery. 2014; 59(4):1123-33 e8. Epub 2014/03/26. doi: 10. 1016/j.jvs.2014.01.041 PMID: 24661896.
16. Mills EJ, Thorlund K, Ioannidis JP. Demystifying trial networks and network meta-analysis. BMJ. 2013; 346:f2914. Epub 2013/05/16. doi: 10.1136/bmj.f2914 PMID: 23674332.
17. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009; 373(9678):1849-60. Epub 2009/06/02. doi: 10.1016/S0140-6736(09) 60503-1 PMID: 19482214; PubMed Central PMCID: PMC2715005.
18. Uchiyama S, Demaerschalk BM, Goto S, Shinohara Y, Gotoh F, Stone WM, et al. Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association. 2009; 18(6):482-90. Epub 2009/11/11. doi: 10.1016/j.jstrokecerebrovasdis.2009.07.010 PMID: 19900653.
19. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. BMJ. 2009; 339:b2535. Epub 2009/07/23. doi: 10.1136/bmj.b2535 PMID: 19622551; PubMed Central PMCID: PMC2714657.
20. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled clinical trials. 1996; 17(1):1-12. Epub 1996/02/01. PMID: 8721797.
21. Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Medical decision making: an international journal of the Society for Medical Decision Making. 2013; 33(5):607-17. Epub 2012/10/30. doi: 10.1177/0272989X12458724 PMID: 23104435; PubMed Central PMCID: PMC3704203.
22. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. Journal of clinical epidemiology. 2011; 64(2):163-71. Epub 2010/08/07. doi: 10.1016/j.jclinepi.2010.03.016 PMID: 20688472.
23. Achana FA, Cooper NJ, Dias S, Lu G, Rice SJ, Kendrick D, et al. Extending methods for investigating the relationship between treatment effect and baseline risk from pairwise meta-analysis to network meta-analysis. Statistics in medicine. 2013; 32(5):752-71. Epub 2012/08/07. doi: 10.1002/sim.5539 PMID: 22865748.
24. Dias S, Sutton AJ, Welton NJ, Ades AE. Evidence synthesis for decision making 3: heterogeneity- subgroups, meta-regression, bias, and bias-adjustment. Medical decision making: an international journal of the Society for Medical Decision Making. 2013; 33(5):618-40. Epub 2013/06/28. doi: 10.1177/ 0272989X13485157 PMID: 23804507; PubMed Central PMCID: PMC3704206.
25. Brooks SP, Gelman A. General Methods for Monitoring Convergence of Iterative Simulations. Journal of Computational and Graphical Statistics. 1998; 7:434-55.
26. Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ. 2008; 337:a1840. Epub 2008/10/18. doi: 10.1136/bmj.a1840 PMID: 18927173; PubMed Central PMCID: PMC2658865.
27. Fowkes FG, Price JF, Stewart MC, Butcher I, Leng GC, Pell AC, et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA: the journal of the American Medical Association. 2010; 303(9):841-8. Epub 2010/03/04. doi: 10.1001/jama.2010.221 PMID: 20197530.
28. Patel MR, Becker RC, Wojdyla DM, Emanuelsson H, Hiatt WR, Horrow J, et al. Cardiovascular Events in Acute Coronary Syndrome Patients With Peripheral Arterial Disease Treated With Ticagrelor Compared to Clopidogrel: Data From the PLATO Trial. Circulation. 2011; 124:A14299.
29. Patel MR, Becker RC, Wojdyla DM, Emanuelsson H, Hiatt WR, Horrow J, et al. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial. European journal of preventive cardiology. 2014. Epub 2014/05/17. doi: 10.1177/2047487314533215 PMID: 24830710.
30. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996; 348(9038):1329-39. Epub 1996/11/16. PMID: 8918275.
31. Belch JJ, Dormandy J, Biasi GM, Cairols M, Diehm C, Eikelboom B, et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. Journal of vascular surgery. 2010; 52(4):825-33, 33 e1-2. Epub 2010/08/04. doi: 10. 1016/j.jvs.2010.04.027 PMID: 20678878.
32. Tepe G, Bantleon R, Brechtel K, Schmehl J, Zeller T, Claussen CD, et al. Management of peripheral arterial interventions with mono or dual antiplatelet therapy-the MIRROR study: a randomised and double-blinded clinical trial. European radiology. 2012; 22(9):1998-2006. Epub 2012/05/10. doi: 10. 1007/s00330-012-2441-2 PMID: 22569995.
33. Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, et al. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. Journal of the American College of Cardiology. 2007; 49(19):1982-8. Epub 2007/05/15. doi: 10.1016/j.jacc.2007.03. 025 PMID: 17498584.
34. Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA. Patients with peripheral arterial disease in the CHARISMA trial. European heart journal. 2009; 30(2):192-201. Epub 2009/01/13. doi: 10.1093/ eurheartj/ehn534 PMID: 19136484.
35. Catalano M, Born G, Peto R. Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial. Journal of internal medicine. 2007; 261 (3):276-84. Epub 2007/02/20. doi: 10.1111/j.1365-2796.2006.01763.x PMID: 17305650.
36. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss L, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013; 61(14):1555-70. Epub 2013/03/12. doi: 10.1016/j.jacc.2013.01.004 PMID: 23473760.
37. Makowsky MJ, McAlister FA, Galbraith PD, Southern DA, Ghali WA, Knudtson ML, et al. Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy. American heart journal. 2008; 155(2):348-55. Epub 2008/01/25. doi: 10. 1016/j.ahj.2007.09.005 PMID: 18215607.
38. Narins CR, Zareba W, Moss AJ, Marder VJ, Ridker PM, Krone RJ, et al. Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction. Archives of internal medicine. 2004; 164(4):440-6. Epub 2004/02/26. doi: 10.1001/ archinte.164.4.440 PMID: 14980996.
39. Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Circulation. 2010; 121(24):2694-701. Epub 2010/05/29. doi: 10.1161/CIR.0b013e3181e3b133 PMID: 20508178.
40. Berger JS, Lala A, Krantz MJ, Baker GS, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials. American heart journal. 2011; 162(1):115-24 e2. Epub 2011/07/12. doi: 10.1016/j.ahj.2011.04.006 PMID: 21742097.